Financial reports
10-Q
2010 Q2
Quarterly report
10 May 10
10-K
2009 FY
Annual report
8 Mar 10
10-Q
2010 Q0
Quarterly report
9 Nov 09
10-Q
2009 Q3
Quarterly report
10 Aug 09
ARS
2008 FY
Annual report to shareholders
14 May 09
10-Q
2009 Q2
Quarterly report
7 May 09
10-K
2008 FY
Annual report
12 Mar 09
10-Q
2009 Q0
Quarterly report
10 Nov 08
10-Q
2008 Q3
Quarterly report
8 Aug 08
Current reports
8-K
Completion of Acquisition or Disposition of Assets
2 Jul 10
8-K
Javelin Receives Notice from Nyse Amex LLC of Non-compliance; Company to Submit Plan to Regain Compliance
4 Jun 10
8-K
Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders
19 Apr 10
8-K
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
12 Apr 10
8-K
Other Events
15 Mar 10
8-K
Entry into a Material Definitive Agreement
10 Mar 10
8-K
Javelin Pharmaceuticals’ Receives FDA PDUFA Date for Dyloject™ NDA
17 Feb 10
8-K
Company Plans Meeting with FDA to Discuss Next Steps
11 Feb 10
8-K
Other Events
2 Feb 10
8-K
Other Events
8 Jan 10
Registration and prospectus
15-12B
Securities registration termination
16 Jul 10
25-NSE
Exchange delisting
6 Jul 10
POS AM
Prospectus update (post-effective amendment)
2 Jul 10
POS AM
Prospectus update (post-effective amendment)
2 Jul 10
POS AM
Prospectus update (post-effective amendment)
2 Jul 10
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Jul 10
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Jul 10
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Jul 10
SC 14D9/A
Tender offer solicitation (amended)
1 Jul 10
SC TO-T/A
Third party tender offer statement (amended)
1 Jul 10
Proxies
DEF 14A
Definitive proxy
30 Apr 09
DEF 14A
Definitive proxy
29 Apr 08
DEF 14A
Definitive proxy
31 May 07
DEF 14A
Definitive proxy
27 Jun 06
PRE 14A
Preliminary proxy
2 Jun 06
DEF 14A
Definitive proxy
8 Aug 05
PRE 14A
Preliminary proxy
30 Jun 05
SC 14F1/A
Statement regarding change in majority of directors (amended)
10 Jan 05
SC 14F1
Statement regarding change in majority of directors
20 Dec 04
DEF 14C
Information statement
26 Jul 02
Other
EFFECT
Notice of effectiveness
6 Jul 10
EFFECT
Notice of effectiveness
6 Jul 10
EFFECT
Notice of effectiveness
6 Jul 10
CT ORDER
Confidential treatment order
18 Aug 09
CT ORDER
Confidential treatment order
12 Dec 08
EFFECT
Notice of effectiveness
12 Feb 08
EFFECT
Notice of effectiveness
26 Sep 07
EFFECT
Notice of effectiveness
12 Feb 07
EFFECT
Notice of effectiveness
13 Nov 06
CORRESP
Correspondence with SEC
9 Nov 06